from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3465/rmlC

LFCtreatmentdescriptionclass of inhibitor

-0.436

Amikacinug/mL Amikacintranslation

-0.623

Cap5-10ug/mL Capreomycintranslation

-0.742

Rox10-50 ug/mL Roxithromycintranslation

0.787

SM2-5 ug/mL Streptomycintranslation

-1.181

Tet5-10 ug/mL Tetracyclinetranslation

0.467

Rif0.2-5ug/mL Rifampicintranscription

0.388

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.487

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.359

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.006

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.135

Clofazimine10-13 ug/mL Clofaziminerespiration

0.416

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.501

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.530

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.487

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.320

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.209

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.238

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.069

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.068

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.250

KCN5-20 ug/mL Potassium cyaniderespiration

0.152

NaN30.2-2 mM Sodium aziderespiration

0.663

Nigericin50 uM Nigericinrespiration

-1.077

TRC10-150 ug/mL Triclosanrespiration

-1.759

TRZ10-25 ug/mL Thioridazinerespiration

-2.581

Valinomycin0.5-10 uM Valinomycinrespiration

1.432

ZnSO42 mM ZnSO4respiration

1.372

menadione6-10 ug/mL Menadionerespiration

-0.432

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.310

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.095

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.586

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.848

NRP_1Non-replicating persistence stage 1dosRassociated

0.688

Amp0.2mg/mL AmpicillincellWall

0.031

Cephalexin20-100 ug/mL CephalexincellWall

0.529

Cerulenin0.32-5 ug/mL CerulenincellWall

0.005

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.731

EMB10-20 ug/mL EthambutolcellWall

0.912

Eta12-40 ug/mL EthionamidecellWall

0.993

INH0.2-0.4 ug/mL IsoniazidcellWall

0.802

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.618

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.184

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.044

BZA0.12 mg/mL BenzamidearomaticAmides

-0.014

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.513

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.047

H2O24 mM hydrogen peroxideDNAdamaging

0.483

Levo10 ug/mL LevofloxacinDNAdamaging

0.438

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.296

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.445

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.569

UVUV-irradiationDNAdamaging

1.801

ARP41-4 ug/mL Antitubercular compound ARP4?

0.361

Antimycin12.5-50 ug/mL Antimycin A?

-0.045

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.428

PA_110-50 ug/mL Antitubercular compound PA-1?

0.147

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.131

PA8240.2-2 ug/mL PA-824?

-0.671

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.476

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.229

Verapamil50 uM Verapamil?

0.555

mercaptoethanol2 mM 2-Mercaptoethanol?

0.177

methoxatin10-20 ug/mL Methoxatin?